SG Americas Securities LLC boosted its position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 222.5% during the 4th quarter, HoldingsChannel.com reports. The firm owned 23,927 shares ...
Learn more about whether Ionis Pharmaceuticals, Inc. or PTC Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
The Focused Ion Beam (FIB) market is an integral segment within the broader landscape of semiconductor manufacturing and materials science. FIB technology has witnessed significant advancements in ...
Anthro Energy, developers of scalable solutions to solve the tradeoff between battery energy density and safety, announced the launch of its proprietary Anthro Proteustm electrolyte technology. Anthro ...